静脉血栓栓塞的药理管理的新视野
Andreas Verstraete1,2, Quentin Van Thillo1, Thomas Vanassche1,2
1Department of Cardiovascular Diseases University Hospitals Leuven Leuven Belgium.
HemaSphere
|June 5, 2025
概括
对于静脉血栓塞栓症 (VTE) 管理,需要新的抗凝剂. 研究探索了改善治疗疗效和安全的新目标,解决当前直接口服抗凝剂 (DOAC) 的局限性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
- 血管生物学 血管生物学
背景情况:
- 静脉血栓塞栓症 (VTE) 尽管有直接口服抗凝剂 (DOAC),但仍面临重大挑战.
- 目前的治疗方法面临的局限性包括复发事件,出血风险,以及特定患者群体的排除在试验之外.
- 在急性和长期VTE管理方面,仍然存在未得到满足的需求.
研究的目的:
- 审查最近在药理性VTE治疗中的临床进展.
- 突出新型抗凝剂的目标和策略.
- 解决现有治疗方法的局限性,并探索VTE治疗的新途径.
主要方法:
- 关于药理性VTE管理的当前文献的综述.
- 探索凝血和纤维素分解中的新目标.
- 针对白细胞与血管壁相互作用的策略的研究.
主要成果:
- 在临床前和第二阶段研究中,XI因子抑制剂在血栓形成管理和血静保持方面表现有前途.
- 目前正在研究向内源性纤维溶解系统 (例如α2-抗等离子素).
- 抑制白细胞-内皮细胞相互作用是另一种治疗策略.
结论:
- 创新的抗凝剂对于有效的VTE管理至关重要.
- 新的目标有可能改善VTE治疗结果和安全性.
- 需要进行进一步的临床试验,特别是第三阶段,以确认新兴疗法的疗效.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
160
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
160
Venous Return
3.4K
The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
3.4K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
499
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
499


